Clinical Trials Patient Summaries
Prostate cancer clinical trials descriptions written in formats that are easily understood by patients. Includes information identifying the locations and contacts for each trial.
Libertas Patient Summary – Metastatic Castration Sensitive
Coming Soon Title: A Phase 3, Open-label, Randomized, Prospective Study of Apalutamide With Continued Versus Intermittent Androgen-Deprivation...
Lorikeet Patient Summary – Metastatic Castration Resistant
Background Information: Our immune system protects us from disease by killing bacteria and viruses. It also helps fight cancer. A T-cell is one type...
Promise Registry – All Patients
PROMISE is a nationwide registry of prostate cancer patients with inherited mutations by screening approximately 5,000 participants with a prostate...
AMG 509 Patient Summary – Metastatic Castration Resistant
This clinical trial is for patients who have metastatic castration resistant prostate cancer (mCRPC) and failed to respond to abiraterone acetate or...
Find Your Trial
Low Risk
Intermediate Risk
High Risk
Cancer Recurrence
Non-Metastatic Castration Resistant
Metastatic Castration Sensitive
Metastatic Castration Resistant
This information is for educational purposes only and not intended as medical advice.
Patients should consult their medical doctor for advice and recommendations about specific clinical trials.
